Home /Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy

Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy

Submitted by dcc on Mon, 02/14/2022 - 15:04
TitlePrognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
Publication TypeJournal Article
Year of Publication2021
AuthorsTjokrowidjaja, A, Friedlander, M, Lord, SJ, Asher, R, Rodrigues, M, Ledermann, JA, Matulonis, UA, Oza, AM, Bruchim, I, Huzarski, T, Gourley, C, Harter, P, Vergote, I, Scott, CL, Meier, W, Shapira-Frommer, R, Milenkova, T, Pujade-Lauraine, E, Gebski, V, Lee, CK
JournalEuropean Journal of Cancer
Volume154
Pagination190 - 200
Date PublishedJan-09-2021
ISSN09598049
URLhttps://pubmed.ncbi.nlm.nih.gov/34293664/
DOI10.1016/j.ejca.2021.06.024
Short TitleEuropean Journal of Cancer